VINEETLAB.NS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 30, 2026
Report Source: 2026 2nd Quarter Report
Vineet Laboratories Ltd. Stock Analysis VINEETLAB.NS
Vineet Laboratories Ltd. specializes in pharmaceutical intermediates and fine chemicals. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-06-15. The firm specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The firm also exports API intermediates, fine chemicals, and custom synthesis molecules.
Read More Vineet Laboratories Ltd (VINEETLAB.NS) Chart
Key Statistics of Vineet Laboratories Ltd (VINEETLAB.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹34.51Volume
61.63KP/E Ratio (TTM)
-52 Week Range
Market Cap
714.86MAvg. Volume
165.15KDividend Yield
-Financial Metrics & Statements of Vineet Laboratories Ltd (VINEETLAB.NS)
FAQ's for Vineet Laboratories Ltd (VINEETLAB.NS)
- According to Musaffa’s Shariah screening methodology, Vineet Laboratories Ltd (VINEETLAB.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.